ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer ...

Acupath Laboratories announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate ...

Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...

Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of controversy.

The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...

UK National Screening Committee rejects call from Olympic legend Sir Chris Hoy to offer PSA test to all men at higher risk of ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...

The UK's National Screening Committee has concluded its review of prostate cancer screening in the UK, saying that the harms of a large-scale, national programme would outweigh the benefits. The ...

UK experts have recommended that only a small group of high-risk men should be eligible for regular testing for prostate ...